255826-65-4

Basic information

• Product Name: Benzenamine, N-(2E)-2-butenylidene-4-methoxy-, [N(E)]- (9CI)
• Synonyms: Benzenamine, N-(2E)-2-butenylidene-4-methoxy-, [N(E)]- (9CI)
• CAS NO: 255826-65-4
• Molecular Formula: C11H13NO
• Molecular Weight: 175.22702
• Product Categories: METHOXY
• Mol File: 255826-65-4.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 285.9±32.0 °C(Predicted)
• Appearance: /
• Density: 0.91±0.1 g/cm3(Predicted)
• PKA: 4.79±0.50(Predicted)
• CAS DataBase Reference: Benzenamine, N-(2E)-2-butenylidene-4-methoxy-, [N(E)]- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, N-(2E)-2-butenylidene-4-methoxy-, [N(E)]- (9CI)(255826-65-4)
• EPA Substance Registry System: Benzenamine, N-(2E)-2-butenylidene-4-methoxy-, [N(E)]- (9CI)(255826-65-4)

Safety Data

• Hazardous Substances Data: 255826-65-4(Hazardous Substances Data)

Upstream product

• 123-73-9 trans-Crotonaldehyde 
• 104-94-9 4-methoxy-aniline 
• 123-73-9 crotonaldehyde 
• 7757-82-6 sodium sulfate 

Downstream Products

• 101535-98-2 cis-3-methoxy-1-(4-methoxyphenyl)-4-(prop-1-enyl)azetidin-2-one 

Relevant articles and documents

Promoting Frustrated Lewis Pairs for Heterogeneous Chemoselective Hydrogenation via the Tailored Pore Environment within Metal–Organic Frameworks

Frustrated Lewis pairs (FLPs) have recently been advanced as efficient metal-free catalysts for catalytic hydrogenation, but their performance in chemoselective hydrogenation, particularly in heterogeneous systems, has not yet been achieved. Herein, we demonstrate that, via tailoring the pore environment within metal–organic frameworks (MOFs), FLPs not only can be stabilized but also can develop interesting performance in the chemoselective hydrogenation of α,β-unsaturated organic compounds, which cannot be achieved with FLPs in a homogeneous system. Using hydrogen gas under moderate pressure, the FLP anchored within a MOF that features open metal sites and hydroxy groups on the pore walls can serve as a highly efficient heterogeneous catalyst to selectively reduce the imine bond in α,β-unsaturated imine substrates to afford unsaturated amine compounds.

Taxoid anti-tumor agents and pharmaceutical compositions thereof

Pharmaceutical compositions, methods of administration, and methods of treatment of cancer with new generation taxoids, of formulas (I) and (II), and derivatives thereof, are described: 1

Taxoid anti-tumor agents and pharmaceutical compositions thereof

This invention relates to a taxoid of the formula (I): STR1 wherein R1 is a C3 -C5 alkyl or alkenyl or trifluoromethyl radical; R2 is a C3 -C5 branched alkyl radical; R3 and Rsu